Page last updated: 2024-11-12

apicularen a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

apicularen A: isolated from Chondromyces; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10718000
CHEMBL ID194587
SCHEMBL ID82470
MeSH IDM0302201

Synonyms (7)

Synonym
apicularen a
CHEMBL194587
SCHEMBL82470
220757-04-0
(2z,4z)-n-[(e)-3-[(1s,11s,13r,15r)-7,15-dihydroxy-9-oxo-10,17-dioxatricyclo[11.3.1.03,8]heptadeca-3(8),4,6-trien-11-yl]prop-1-enyl]hepta-2,4-dienamide
(-)-apicularen a
apicularene a

Research Excerpts

Overview

Apicularen A is a novel antitumor agent and strongly induces death in tumor cells.

ExcerptReferenceRelevance
"Apicularen A is a novel antitumor agent and strongly induces death in tumor cells. "( Apicularen A acetate induces cell death via AIF translocation and disrupts the microtubule network by down-regulating tubulin in HM7 human colon cancer cells.
Hong, TH; Hwang, BD; Jung, YH; Kim, H; Kim, JS; Kweon, GR; Lim, K; Park, JH; Park, JI; Seo, KS; Song, KS; Yoon, WH; Yun, EJ, 2013
)
3.28

Effects

ExcerptReferenceRelevance
"Apicularen A has been shown to cause growth inhibition and apoptosis in several cancer cell lines. "( Apicularen A induces cell death through Fas ligand up-regulation and microtubule disruption by tubulin down-regulation in HM7 human colon cancer cells.
Ahn, JW; Hwang, BD; Kim, JS; Lee, YC; Li, G; Lim, K; Nam, HT; Park, JH; Park, JI; Seo, KS; Song, KS; Yoon, WH; Yun, EJ; Zee, O, 2007
)
3.23

Treatment

ExcerptReferenceRelevance
"Apicularen A treatment of HM7 cells inhibited cell growth and this inhibition was partially rescued by z-VAD-fmk. "( Apicularen A induces cell death through Fas ligand up-regulation and microtubule disruption by tubulin down-regulation in HM7 human colon cancer cells.
Ahn, JW; Hwang, BD; Kim, JS; Lee, YC; Li, G; Lim, K; Nam, HT; Park, JH; Park, JI; Seo, KS; Song, KS; Yoon, WH; Yun, EJ; Zee, O, 2007
)
3.23
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID255780Cytotoxicity against 1A9 human ovarian carcinoma cells2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Joys of molecules. 2. Endeavors in chemical biology and medicinal chemistry.
AID311302Inhibition of tobacco hornworm V-ATPase2007Journal of natural products, Aug, Volume: 70, Issue:8
Side-chain truncation of apicularen A by olefin cross-metathesis with ethylene.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (3.45)18.2507
2000's21 (72.41)29.6817
2010's7 (24.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.18 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index5.40 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.90%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (93.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]